{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:41:59Z","timestamp":1767861719483,"version":"3.49.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"King Abdullah International Medical Research Center (KAIMRC) Scholar"},{"name":"Becas-Chile Scholarship"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jconrel.2018.10.020","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T12:32:27Z","timestamp":1539693147000},"page":"111-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Intranasal immunization with aluminum salt-adjuvanted dry powder vaccine"],"prefix":"10.1016","volume":"292","author":[{"given":"Sachin G.","family":"Thakkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1028-134X","authenticated-orcid":false,"given":"Zachary N.","family":"Warnken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riyad F.","family":"Alzhrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange A.","family":"Valdes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaziz M.","family":"Aldayel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Robert O.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengrong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jconrel.2018.10.020_bb0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.coi.2010.04.004","article-title":"New adjuvants for human vaccines","volume":"22","author":"Mbow","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2018.10.020_bb0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1389-0344(01)00101-0","article-title":"Recent developments in adjuvants for vaccines against infectious diseases","volume":"18","author":"Derek","year":"2001","journal-title":"Biomol. Eng."},{"key":"10.1016\/j.jconrel.2018.10.020_bb0015","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/15058","article-title":"Advances in vaccine adjuvants","volume":"17","author":"Singh","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2018.10.020_bb0020","series-title":"Temperature sensitivity of vaccines","author":"Milstien","year":"2006"},{"key":"10.1016\/j.jconrel.2018.10.020_bb0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2015.02.035","article-title":"A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution","volume":"204","author":"Li","year":"2015","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2018.10.020_bb0030","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1080\/21645515.2016.1259042","article-title":"The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures","volume":"13","author":"Thakkar","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2018.10.020_bb0035","series-title":"Vaccines: ensuring sustainable supplies. m\u00e9decins sans fronti\u00e8res access campaign","year":"2012"},{"issue":"2","key":"10.1016\/j.jconrel.2018.10.020_bb0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0168-3659(97)00036-9","article-title":"Current options for vaccine delivery systems by mucosal routes","volume":"48","author":"Mestecky","year":"1997","journal-title":"J. Control. Release"},{"issue":"1\u20133","key":"10.1016\/j.jconrel.2018.10.020_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-409X(01)00162-4","article-title":"Nasal vaccines","volume":"51","author":"Davis","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2018.10.020_bb0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0264-410X(95)00174-Y","article-title":"Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin","volume":"14","author":"Hashigucci","year":"1996","journal-title":"Vaccine"},{"issue":"21\u221222","key":"10.1016\/j.jconrel.2018.10.020_bb0055","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1016\/S0264-410X(03)00224-X","article-title":"Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus","volume":"21","author":"Smith","year":"2003","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jconrel.2018.10.020_bb0060","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.4049\/jimmunol.104.6.1396","article-title":"Effect of physical state and route of inoculation of diphtheria toxoid on the formation of nasal secretory and serum antibodies in man","volume":"104","author":"Butler","year":"1970","journal-title":"J. Immunol."},{"issue":"17","key":"10.1016\/j.jconrel.2018.10.020_bb0065","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0264-410X(98)00066-8","article-title":"Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit","volume":"16","author":"Isaka","year":"1998","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jconrel.2018.10.020_bb0070","first-page":"5","article-title":"J M. Comparison of systemic and mucosal responses of mice to aluminium-adsorbed diphtheria toxoid between intranasal administration and subcutaneous injection","volume":"45","author":"Isaka","year":"2001","journal-title":"Nagoya Med. J."},{"issue":"3","key":"10.1016\/j.jconrel.2018.10.020_bb0075","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.coi.2011.03.009","article-title":"Defending the mucosa: adjuvant and carrier formulations for mucosal immunity","volume":"23","author":"Lawson","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"11","key":"10.1016\/j.jconrel.2018.10.020_bb0080","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1080\/21645515.2017.1365995","article-title":"Nasal aluminum (oxy)hydroxide enables adsorbed antigens to induce specific systemic and mucosal immune responses","volume":"13","author":"Xu","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"issue":"6","key":"10.1016\/j.jconrel.2018.10.020_bb0085","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.vaccine.2004.06.049","article-title":"A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats","volume":"23","author":"Huang","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jconrel.2018.10.020_bb0090","doi-asserted-by":"crossref","DOI":"10.1208\/pt0804081","article-title":"Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination","volume":"8","author":"Garmise","year":"2007","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"10.1016\/j.jconrel.2018.10.020_bb0095","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.vaccine.2003.09.012","article-title":"Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan","volume":"22","author":"McNeela","year":"2004","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.jconrel.2018.10.020_bb0100","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1086\/657087","article-title":"Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues","volume":"202","author":"El-Kamary","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2018.10.020_bb0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejpb.2017.11.001","article-title":"Intranasal immunization with dry powder vaccines","volume":"122","author":"Bahamondez-Canas","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.jconrel.2018.10.020_bb0110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jps.10294","article-title":"Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application","volume":"92","author":"Maa","year":"2003","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2018.10.020_bb0115","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/80538","article-title":"Epidermal immunization by a needle-free powder delivery technology: immunogenicity of influenza vaccine and protection in mice","volume":"6","author":"Chen","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2018.10.020_bb0120","series-title":"United States Pharmacopeia <616> bulk density and tapped density. USP 29\/NF","first-page":"2638","year":"2006"},{"key":"10.1016\/j.jconrel.2018.10.020_bb0125","series-title":"United States Pharmacopeia <1174> Powder Flow. USP 29\/NF","year":"2004"},{"issue":"4","key":"10.1016\/j.jconrel.2018.10.020_bb0130","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1021\/acs.molpharmaceut.7b00702","article-title":"Personalized medicine in nasal delivery: the use of patient-specific administration parameters to improve nasal drug targeting using 3D printed nasal replica casts","volume":"15","author":"Warnken","year":"2018","journal-title":"Mol. Pharmaceut."},{"key":"10.1016\/j.jconrel.2018.10.020_bb0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.provac.2011.07.016","article-title":"Novel formulation concept for particulate uptake of vaccines via the nasal associated lymphoid tissue","volume":"4","author":"Scherlie\u00df","year":"2011","journal-title":"Procedia Vaccinol."},{"key":"10.1016\/j.jconrel.2018.10.020_bb0140","first-page":"75","article-title":"Practices of coating collection surfaces of cascade impactors: a survey of members of the European Pharmaceutical Aerosol Group (EPAG)","volume":"14","author":"Mitchell","year":"2003","journal-title":"Drug Deliv. Lung."},{"key":"10.1016\/j.jconrel.2018.10.020_bb0145","series-title":"Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration patent","author":"Cui","year":"2017"},{"key":"10.1016\/j.jconrel.2018.10.020_bb0150","series-title":"DNA Vaccines: Methods and Protocols: Springer Science & Business Media","author":"Lowrie","year":"2000"},{"issue":"1","key":"10.1016\/j.jconrel.2018.10.020_bb0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2009.08.023","article-title":"Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles","volume":"141","author":"Sloat","year":"2010","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.jconrel.2018.10.020_bb0160","series-title":"AAS, GFAAS, ICP or ICP-MS? Which technique should I use. An elementary overview of elemental analysis","author":"Elemental","year":"2001"},{"key":"10.1016\/j.jconrel.2018.10.020_bb0165","series-title":"Vaccine Adjuvants: Methods and Protocols. Methods in Molecular Biology","first-page":"181","article-title":"methods to prepare aluminum salt-adjuvanted vaccines","author":"Thakkar","year":"2017"},{"key":"10.1016\/j.jconrel.2018.10.020_bb0170","series-title":"Recommendations for the assessment of adjuvants (immunopotentiators). Immunological adjuvants and vaccines","first-page":"213","author":"Stewart-Tull","year":"1989"},{"key":"10.1016\/j.jconrel.2018.10.020_bb0175","series-title":"Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences","author":"Martin","year":"1993"},{"issue":"3","key":"10.1016\/j.jconrel.2018.10.020_bb0180","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s11095-012-0922-2","article-title":"WRO. Respirable low-density microparticles formed in situ from aerosolized brittle matrices","volume":"30","author":"Watts","year":"2013","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2018.10.020_bb0185","first-page":"237","article-title":"The Waldeyer's ring","volume":"54","author":"Hellings","year":"2000","journal-title":"Acta Otorhinolaryngol. Belg."},{"issue":"3","key":"10.1016\/j.jconrel.2018.10.020_bb0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2249.2003.02311.x","article-title":"Nasal-associated lymphoid tissue (NALT): frequency and localization in young children","volume":"134","author":"Debertin","year":"2003","journal-title":"Clin. Exp. Immunol."},{"issue":"36","key":"10.1016\/j.jconrel.2018.10.020_bb0195","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1016\/j.vaccine.2015.07.022","article-title":"Mucosal vaccination by the intranasal route. Nose-associated lymphoid tissue (NALT)-Structure, function and species differences","volume":"33","author":"Pabst","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jconrel.2018.10.020_bb0200","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11095-013-1157-6","article-title":"Validation of anatomical models to study aerosol deposition in human nasal cavities","volume":"31","author":"Le Guellec","year":"2014","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2018.10.020_bb0205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0264-410X(93)90190-9","article-title":"Adjuvants\u2014a balance between toxicity and adjuvanticity","volume":"11","author":"Gupta","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2018.10.020_bb0210","series-title":"Vaccine Adjuvants: Preparation methods and Research protocols","author":"O'Hagan","year":"2000"},{"issue":"12\u221213","key":"10.1016\/j.jconrel.2018.10.020_bb0215","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0264-410X(97)00041-8","article-title":"In vivo absorption of aluminium-containing vaccine adjuvants using 26Al","volume":"15","author":"Flarend","year":"1997","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.jconrel.2018.10.020_bb0220","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/S0264-410X(02)00170-6","article-title":"Elimination of aluminum adjuvants","volume":"20","author":"Hem","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2018.10.020_bb0225","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/br.25.3.237-240.1961","article-title":"Distribution and deposition of inhaled particles in respiratory tract","volume":"25","author":"Hatch","year":"1961","journal-title":"Bacteriol. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2018.10.020_bb0230","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/archinte.1973.00320070056006","article-title":"Deposition of inhaled aerosols","volume":"131","author":"Stuart","year":"1973","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2018.10.020_bb0235","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/jcbfm.2013.41","article-title":"Accessing the brain: the nose may know the way","volume":"33","author":"Djupesland","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.jconrel.2018.10.020_bb0240","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/toxsci\/kfp046","article-title":"Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size","volume":"109","author":"Pauluhn","year":"2009","journal-title":"Toxicol. Sci."},{"issue":"8540","key":"10.1016\/j.jconrel.2018.10.020_bb0245","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0140-6736(87)92288-4","article-title":"Uptake of aluminium into central nervous system along nasal-olfactory pathways","volume":"1","author":"Perl","year":"1987","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jconrel.2018.10.020_bb0250","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/01926230600713475","article-title":"The nose revisited: a brief review of the comparative structure, function, and toxicologic pathology of the nasal epithelium","volume":"34","author":"Harkema","year":"2006","journal-title":"Toxicol. Patho."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2018.10.020_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2014.08.032","article-title":"Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants","volume":"475","author":"Dehghan","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2018.10.020_bb0260","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jps.20484","article-title":"Anthrax vaccine powder formulations for nasal mucosal delivery","volume":"95","author":"Jiang","year":"2006","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2018.10.020_bb0265","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jps.22742","article-title":"Stable dry powder formulation for nasal delivery of anthrax vaccine","volume":"101","author":"Wang","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.jconrel.2018.10.020_bb0270","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.vaccine.2016.01.064","article-title":"Preclinical dose-ranging studies of a novel dry powder norovirus vaccine formulation","volume":"34","author":"Springer","year":"2016","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jconrel.2018.10.020_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177310","article-title":"Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder","volume":"12","author":"Ball","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jconrel.2018.10.020_bb0280","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4161\/hv.3.3.4011","article-title":"Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge","volume":"3","author":"Huang","year":"2007","journal-title":"Hum Vaccin."},{"issue":"43","key":"10.1016\/j.jconrel.2018.10.020_bb0285","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1016\/j.vaccine.2008.07.062","article-title":"A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge","volume":"26","author":"Klas","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jconrel.2018.10.020_bb0290","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/10611860903434035","article-title":"Preparation and in vivo study of dry powder microspheres for nasal immunization","volume":"18","author":"Tafaghodi","year":"2010","journal-title":"J. Drug Target."},{"issue":"2","key":"10.1016\/j.jconrel.2018.10.020_bb0295","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1128\/IAI.71.2.726-732.2003","article-title":"Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a","volume":"71","author":"Mills","year":"2003","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.jconrel.2018.10.020_bb0300","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.vaccine.2008.12.013","article-title":"Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine","volume":"27","author":"Coucke","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jconrel.2018.10.020_bb0305","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1128\/IAI.73.12.8256-8265.2005","volume":"73","author":"Huo","year":"2005","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.jconrel.2018.10.020_bb0310","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1086\/426865","article-title":"Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms","volume":"191","author":"Mikszta","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"18","key":"10.1016\/j.jconrel.2018.10.020_bb0315","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.vaccine.2006.02.024","article-title":"An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits","volume":"24","author":"Wimer-Mackin","year":"2006","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.jconrel.2018.10.020_bb0320","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1016\/j.vaccine.2011.05.027","article-title":"Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine","volume":"29","author":"Velasquez","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jconrel.2018.10.020_bb0325","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.clim.2012.05.006","article-title":"Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers","volume":"144","author":"Ramirez","year":"2012","journal-title":"Clin. Immunol."},{"issue":"8","key":"10.1016\/j.jconrel.2018.10.020_bb0330","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2018.10.020_bb0335","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/jps.21523","article-title":"Vaccine adjuvants: current challenges and future approaches","volume":"98","author":"Wilson-Welder","year":"2009","journal-title":"J. Pharm. Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918305911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918305911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:37:01Z","timestamp":1759160221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365918305911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":67,"alternative-id":["S0168365918305911"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.10.020","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal immunization with aluminum salt-adjuvanted dry powder vaccine","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}